Enveric Biosciences – Therapeutic Psychedelics
Dr. Bob Dagher, MD, Chief Medical Officer at Enveric Biosciences, a biotechnology company dedicated to developing novel small-molecule therapeutics to transform the treatment of anxiety, depression, and addiction disorders discusses the company’s lead candidate, a next-generation, psilocybin analogue (psychedelics), that has been rationally designed to optimize delivery, offer dosing flexibility, and achieve therapeutic benefit at a low dose. Enveric has harnessed the world’s foremost library of psychedelic derivatives, The Psybrary™, a unique discovery, and development platform.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Depression. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Depression and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Depression?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Bob Dagher, MD, Chief Medical Officer at Enveric Biosciences, a biotechnology company dedicated to developing novel small-molecule therapeutics to transform the treatment of anx…
- Key Point: Enveric has harnessed the world’s foremost library of psychedelic derivatives, The Psybrary™, a unique discovery, and development platform.
- Key Point: Bob Dagher has over 20 years of clinical research experience within neuroscience in academia and industry organizations and has fostered the development of several small molecul…
- Healthcare Insight: Stay informed with the latest healthcare news and developments from Health Professional Radio.
- Healthcare Insight: Stay informed with the latest healthcare news and developments from Health Professional Radio.
Dr. Bob Dagher has over 20 years of clinical research experience within neuroscience in academia and industry organizations and has fostered the development of several small molecule drugs and biologics across all stages of drug development, targeting the treatment of psychiatric, neurological and rare diseases.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.



